• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢病毒载体在人角质形成细胞基因组中的长期整合位点选择

Prolonged Integration Site Selection of a Lentiviral Vector in the Genome of Human Keratinocytes.

作者信息

Qian Wei, Wang Yong, Li Rui-Fu, Zhou Xin, Liu Jing, Peng Dai-Zhi

机构信息

Institute of Burn Research, Southwest Hospital and Tissue Engineering Research Unit, State Key Laboratory of Trauma, Burns, and Combined Injury, 3rd Military Medical University, Chongqing, China (mainland).

出版信息

Med Sci Monit. 2017 Mar 3;23:1116-1122. doi: 10.12659/msm.903094.

DOI:10.12659/msm.903094
PMID:28255155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5347986/
Abstract

BACKGROUND Lentiviral vectors have been successfully used for human skin cell gene transfer studies. Defining the selection of integration sites for retroviral vectors in the host genome is crucial in risk assessment analysis of gene therapy. However, genome-wide analyses of lentiviral integration sites in human keratinocytes, especially after prolonged growth, are poorly understood. MATERIAL AND METHODS In this study, 874 unique lentiviral vector integration sites in human HaCaT keratinocytes after long-term culture were identified and analyzed with the online tool GTSG-QuickMap and SPSS software. RESULTS The data indicated that lentiviral vectors showed integration site preferences for genes and gene-rich regions. CONCLUSIONS This study will likely assist in determining the relative risks of the lentiviral vector system and in the design of a safe lentiviral vector system in the gene therapy of skin diseases.

摘要

背景 慢病毒载体已成功用于人类皮肤细胞基因转移研究。确定逆转录病毒载体在宿主基因组中的整合位点选择对于基因治疗的风险评估分析至关重要。然而,对于人类角质形成细胞中慢病毒整合位点的全基因组分析,尤其是在长期生长后,了解甚少。材料与方法 在本研究中,利用在线工具GTSG-QuickMap和SPSS软件对长期培养后的人类HaCaT角质形成细胞中874个独特的慢病毒载体整合位点进行了鉴定和分析。结果 数据表明慢病毒载体对基因和基因丰富区域表现出整合位点偏好。结论 本研究可能有助于确定慢病毒载体系统的相对风险,并有助于设计用于皮肤病基因治疗的安全慢病毒载体系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8fb/5347986/a2b8c29612bc/medscimonit-23-1116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8fb/5347986/9dc8db31eafe/medscimonit-23-1116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8fb/5347986/a2b8c29612bc/medscimonit-23-1116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8fb/5347986/9dc8db31eafe/medscimonit-23-1116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8fb/5347986/a2b8c29612bc/medscimonit-23-1116-g002.jpg

相似文献

1
Prolonged Integration Site Selection of a Lentiviral Vector in the Genome of Human Keratinocytes.慢病毒载体在人角质形成细胞基因组中的长期整合位点选择
Med Sci Monit. 2017 Mar 3;23:1116-1122. doi: 10.12659/msm.903094.
2
Risk assessment in skin gene therapy: viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors.皮肤基因治疗中的风险评估:自失活慢病毒载体转导的角质细胞中通过前病毒转录通读产生的病毒-细胞融合转录本。
Gene Ther. 2011 Jul;18(7):674-81. doi: 10.1038/gt.2011.12. Epub 2011 Mar 3.
3
Comparison of gene-trapping efficiency between retroviral and lentiviral vectors in mouse embryonic stem cells.逆转录病毒载体和慢病毒载体在小鼠胚胎干细胞中的基因捕获效率比较。
Biochem Biophys Res Commun. 2012 Aug 24;425(2):297-303. doi: 10.1016/j.bbrc.2012.07.085. Epub 2012 Jul 25.
4
Lentiviral integration preferences in transgenic mice.转基因小鼠中的慢病毒整合偏好性。
Genesis. 2008 Dec;46(12):711-8. doi: 10.1002/dvg.20435.
5
Lentiviral vector integration sites in human NOD/SCID repopulating cells.人NOD/SCID重建造血细胞中的慢病毒载体整合位点。
J Gene Med. 2006 Oct;8(10):1197-207. doi: 10.1002/jgm.958.
6
A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.γ-逆转录病毒载体与慢病毒载体对人角质形成细胞靶向性能的比较
Hum Gene Ther. 2003 Nov 1;14(16):1579-85. doi: 10.1089/104303403322495089.
7
Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.逆转录病毒载体插入 NOD/SCID 重建造血的人外周血祖细胞中,优先发生在转录起始区域附近和内含子中。
Mol Ther. 2004 Nov;10(5):874-81. doi: 10.1016/j.ymthe.2004.08.001.
8
Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome.为治疗威斯科特-奥尔德里奇综合征而研发的慢病毒载体的多样基因组整合。
J Gene Med. 2009 Aug;11(8):645-54. doi: 10.1002/jgm.1346.
9
Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.用γ逆转录病毒、慢病毒或泡沫病毒转导的长期再增殖细胞犬模型中的独特整合谱。
Hum Gene Ther. 2007 May;18(5):423-34. doi: 10.1089/hum.2007.011.
10
Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.灵长类动物再增殖细胞中源自HIV的慢病毒载体和基于MLV的γ-逆转录病毒载体整合位点的比较。
Mol Ther. 2007 Jul;15(7):1356-65. doi: 10.1038/sj.mt.6300159. Epub 2007 Apr 17.

引用本文的文献

1
Dual AAV vectors for efficient delivery of large transgenes.用于高效递送大型转基因的双腺相关病毒载体。
Nat Protoc. 2025 Sep 11. doi: 10.1038/s41596-025-01243-8.
2
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells.当前和未来用于生成和应用基因工程 CAR-T 和 TCR-T 细胞的概念。
Front Immunol. 2023 Mar 6;14:1121030. doi: 10.3389/fimmu.2023.1121030. eCollection 2023.
3
Viral vector platforms within the gene therapy landscape.病毒载体平台在基因治疗领域中的应用。

本文引用的文献

1
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras.探索人工LEDGF嵌合体,实现更安全、更随机的慢病毒载体整合图谱
PLoS One. 2016 Oct 27;11(10):e0164167. doi: 10.1371/journal.pone.0164167. eCollection 2016.
2
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives.用于稳定基因治疗的逆转录病毒载体和转座子:进展、当前挑战与展望
J Transl Med. 2016 Oct 12;14(1):288. doi: 10.1186/s12967-016-1047-x.
3
Retroviral DNA Integration.逆转录病毒DNA整合
Signal Transduct Target Ther. 2021 Feb 8;6(1):53. doi: 10.1038/s41392-021-00487-6.
4
Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes.基于组织特异性启动子的报告系统,用于监测 iPS 细胞向心肌细胞的分化。
Sci Rep. 2020 Feb 5;10(1):1895. doi: 10.1038/s41598-020-58050-2.
Chem Rev. 2016 Oct 26;116(20):12730-12757. doi: 10.1021/acs.chemrev.6b00125. Epub 2016 May 20.
4
[Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].[使用逆转录病毒载体的基因治疗:临床试验中的载体开发与生物安全性]
Uirusu. 2015;65(1):27-36. doi: 10.2222/jsv.65.27.
5
Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.表达密码子优化的COL7A1的慢病毒工程化成纤维细胞可恢复隐性营养不良性大疱性表皮松解症中的锚定原纤维。
J Invest Dermatol. 2016 Jan;136(1):284-92. doi: 10.1038/JID.2015.364.
6
Clinical applications of gene therapy for primary immunodeficiencies.基因治疗在原发性免疫缺陷病中的临床应用。
Hum Gene Ther. 2015 Apr;26(4):210-9. doi: 10.1089/hum.2015.047.
7
Functions of noncoding sequences in mammalian genomes.哺乳动物基因组中非编码序列的功能。
Biochemistry (Mosc). 2014 Dec;79(13):1442-69. doi: 10.1134/S0006297914130021.
8
Host factors for retroviral integration site selection.逆转录病毒整合位点选择的宿主因素。
Trends Biochem Sci. 2015 Feb;40(2):108-16. doi: 10.1016/j.tibs.2014.12.001. Epub 2014 Dec 31.
9
Cell cycle status of CD34(+) hemopoietic stem cells determines lentiviral integration in actively transcribed and development-related genes.CD34(+)造血干细胞的细胞周期状态决定慢病毒整合到活跃转录及发育相关基因中。
Mol Ther. 2015 Apr;23(4):683-96. doi: 10.1038/mt.2014.246. Epub 2014 Dec 19.
10
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.LTR 增强子/启动子缺失对 MLV 载体在人造血祖细胞中的整合谱没有影响。
PLoS One. 2013;8(1):e55721. doi: 10.1371/journal.pone.0055721. Epub 2013 Jan 31.